Dexamethasone Dose in Low Volume Bupivacaine USG Supraclavicular Block

Dexamethasone Clinical Trial

Official title:

The Optimal Dose Of Dexamethasone To Be Used As An Adjuvant To Low Volume Bupivacaine Ultrasound Guided Supraclavicular Brachial Plexus Block. A Randomized Controlled Double Blinded Dose Ranging Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03043495
• Other study ID #: DexSupraClav
• Status: Recruiting
• Phase: Phase 4
• First received: February 1, 2017
• Last updated: February 3, 2017
• Start date: October 1, 2016
• Est. completion date: June 1, 2018

Study information

• Verified date: February 2017
• Source: Cairo University
• Contact: Eslam A Shawki, M.D.
• Phone: +201225771017
• Email: eslam.ayman[@]kasralainy.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A dose-ranging study to test various doses of Dexamethasone (2, 4 & 8 mg) to be used as an adjuvant to Local anesthetic drugs in ultrasound guided low volume Supraclavicular brachial plexus block to find the best balance between valuable effects (mainly duration of analgesic Effect) and side-effects (mainly increased random blood sugar levels)

Description:

Brachial plexus nerve blocks (BPBs) for upper extremity surgery provide superior analgesia and reduce opioid consumption. Supraclavicular block anesthetizes the brachial plexus where it is in its most compact form, thus providing a complete and reliable block for upper extremity surgery. Ultrasound guided single injection (SI) and triple injection (TI) techniques were found to provide the same degree of surgical anesthesia at 30 minutes while the TI technique needed more time to perform.

Many studies were conducted to examine the effect of perineural Dexamethasone as a local anesthetic adjuvant in low volume peripheral nerve blocks were it was found to increase the mean duration of analgesia (sensory block) with short, medium and long acting local anesthetics as well as the duration of motor blockade, with a reduction in pain scores at rest during the intermediate (8-12 h) and late (24 h) postoperative periods and in movement at all times. At 24 postoperative hours, cumulative morphine consumption and the rate of nausea or vomiting were also reduced without any reported related serious adverse effects, also the value of its concomitant intravenous use in prolonging the duration of analgesia after regional blocks was studied with promising results that can sometimes be compared to the perineural route but more short-lived and associated with higher increase in blood glucose levels. Dexamethasone's mechanism of action may result from decreased nociceptive C-fibre activity via a direct effect on glucocorticoid receptors and inhibitory effect on potassium channels.(8) Other authors suggest a local vasoconstrictive effect, resulting in reduced local anaesthetic absorption or a systemic anti-inflammatory effect following vascular uptake of the drug.

A debate exists whether perineural corticosteroids are harmful or not, but reports of neurotoxicity seem to be related mainly to the preservative benzyl alcohol and the vehicle polyethylene glycol found in some preparations, also may be related to the presence of insoluble steroid particulate matter in the injectate. Dexamethasone is non-particulate and can be found in a preservative-free formulation. In addition, no significant long-term electrophysiological, behavioural or histological effects for corticosteroids were identified on rat sciatic nerve tissue even some data suggest dexamethasone may actually be neuroprotective. In reality, perineural corticosteroid injections with and without preservative are widely used throughout the world.

Various doses of Dexamethasone were used in local anaesthetic mixtures in regional blocks in various studies, including 4, 5, 8 and 10 mg. In a recent review & meta-analysis by E. Albrecht and his colleagues, sub-group analysis revealed no association between the total dose of perineural Dexamethasone and the mean increase in duration of analgesia showing that Dose-finding studies are needed to better define the optimal balance between dose, effects and side-effects, particularly at doses lower than 4 mg.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: June 1, 2018
• Est. primary completion date: April 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients undergoing surgeries in the upper limb (arm, forearm or hand)

Exclusion Criteria:

• Coagulopathies (with prothrombin concentration less than 60% or INR more than 1.5)

• In-ability to postpone anti-coagulation medications.

• Infection or injury or a lesion at the block site.

• Suspected cervical vertebral column injury necessitating using a neck collar.

• A compromised lung on the contralateral side of the block (Pneumothorax, hemothorax or Pneumonectomy).

• Traumatic vascular injuries or operative interventions (Surgical harvesting) involving arteries of the upper limb on the operative side.

• Patients with communication difficulties.

• Hypersensitivity to local anesthetics and/or Dexamethasone.

• Patients on perioperative intravenous (IV) steroids.

Related Conditions & MeSH terms

• Dexamethasone
• Supraclavicular Brachial Plexus Block

Intervention

Procedure:
• Ultrasound guided supraclavicular brachial plexus block
ultrasound guided Supraclavicular brachial plexus block

Drug:
• Dexamethasone
Various doses of Dexamethasone (2, 4 & 8 mg) to be used as an Adjuvant to Local anesthetic drugs

Locations

Country	Name	City	State
Egypt	Faculty of medicine, Cairo University teaching hospitals (Kasr Alainy)	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Eslam Ayman Mohamed Shawki

Country where clinical trial is conducted

Egypt, 

References & Publications (6)

Al Harbi M, Kaki AM, Kamal A, El-Dawlatly A, Daghistani M, El Tahan MR. A survey of the practice of regional anesthesia in Saudi Arabia. Saudi J Anaesth. 2013 Oct;7(4):367-70. doi: 10.4103/1658-354X.121041. — View Citation

Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia. 2015 Jan;70(1):71-83. doi: 10.1111/anae.12823. Review. — View Citation

Desmet M, Braems H, Reynvoet M, Plasschaert S, Van Cauwelaert J, Pottel H, Carlier S, Missant C, Van de Velde M. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single-shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo-controlled study. Br J Anaesth. 2013 Sep;111(3):445-52. doi: 10.1093/bja/aet109. — View Citation

Fredrickson MJ, Krishnan S, Chen CY. Postoperative analgesia for shoulder surgery: a critical appraisal and review of current techniques. Anaesthesia. 2010 Jun;65(6):608-24. doi: 10.1111/j.1365-2044.2009.06231.x. Review. — View Citation

Neal JM, Hebl JR, Gerancher JC, Hogan QH. Brachial plexus anesthesia: essentials of our current understanding. Reg Anesth Pain Med. 2002 Jul-Aug;27(4):402-28. Review. Erratum in: Reg Anesth Pain Med 2002 Nov-Dec;27(6):625. — View Citation

Rosenfeld DM, Ivancic MG, Hattrup SJ, Renfree KJ, Watkins AR, Hentz JG, Gorlin AW, Spiro JA, Trentman TL. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia. 2016 Apr;71(4):380-8. doi: 10.1111/anae.13409. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Duration of analgesia	The time between injection of Local anesthetic mixture during performing the block and time of administration of the first dose of rescue analgesia at VAS equal or more than 4	24 hours
Secondary	Duration of motor block	The time between injection of Local anesthetic mixture during performing the block and regaining full motor power in the distribution of all 4 nerves represented by score 6 on Modified Lovett rating scale	24 hours
Secondary	Patient Satisfaction score	A point on a 10 point numeric scale where 0 is very dissatisfied and 10 very satisfied one time at the end of the first postoperative 24 hours	24 hours
Secondary	Random Blood glucose levels	Random blood glucose level readings will be obtained from the patient using fast strip test (ACCU-CHEK.) First, upon arrival to the operating theatre, then at the end of the operation then every 8 hours in the first 24 hours postoperatively	24 hours
Secondary	Incidence of PONV	Incidence of postoperative nausea and vomiting	24 hours
Secondary	Incidence of complications	Incidence of Pneumothorax, Nerve injury, Haematoma formation, Intravascular injection	24 hours